Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Clinical trial NCT02276560 · TERMINATED

Trial details

NCT number: NCT02276560
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIA Non-Small Cell Lung Cancer

Start date: 2015-01-01
Primary completion: 2016-06-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.